Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GLEEVEC-RESISTANT LEUKEMIA, CONTAINING, AS ACTIVE INGREDIENT, GINSENOSIDE F1 OR RG3
Document Type and Number:
WIPO Patent Application WO/2016/178510
Kind Code:
A2
Abstract:
The present invention relates to: a pharmaceutical composition for preventing or treating Gleevec-resistant leukemia, containing, as an active ingredient, ginsenoside F1 or Rg3 which exhibits a preventive or treatment effect on Gleevec-resistant leukemia; a method for treating Gleevec-resistant leukemia comprising a step of administering the pharmaceutical composition; and a food composition for preventing or alleviating Gleevec-resistant leukemia. When using the pharmaceutical composition of the present invention, leukemia exhibiting resistance due to conventional Gleevec can be effectively treated, and thus the pharmaceutical composition can be widely used for effective leukemia treatment.
More Like This:
Inventors:
KIM SUN CHANG (KR)
KIM HUN SIK (KR)
KIM HUN SIK (KR)
Application Number:
PCT/KR2016/004699
Publication Date:
November 10, 2016
Filing Date:
May 04, 2016
Export Citation:
Assignee:
INTELLIGENT SYNTHETIC BIOLOGY CT (KR)
International Classes:
A61K31/704; A61K31/506; A61K31/70; A61K45/06
Other References:
See references of EP 3181137A4
Attorney, Agent or Firm:
SON, MIN (KR)
손민 (KR)
손민 (KR)
Download PDF: